Fenbendazole Market – Regional
Analysis
On the basis of region, the
global Fenbendazole
Market is segmented into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa.
Fenbendazole is a broad spectrum
anthelmintic drug of class benzimidazole. Fenbendazole is used to remove
certain gastrointestinal parasites from the stomach and intestines of animals.
It is effective against roundworms, hookworms, whipworms, certain tapeworms,
and parasites called strongyles and strongyloides, respectively. Fenbendazole
acts as an effective de-wormer as it controls & destroys these worms by
preventing their growth and reproduction.
Fenbendazole Market Driver
Increasing research and
development activities for enhancing the efficiency of fenbendazole in treating
various diseases in animals and humans is a major factor boosting growth of the
fenbendazole market. For instance, in August 2018, researchers from National
Centre for Human Genome Studies and Research (NCHGSR), India, reported that
fenbendazole has potential to act as an effective anti-cancer agent.
Fenbendazole can also be effective remedy in evading drug resistance commonly
encountered in cancer therapy. To study this, researchers first treated human
non-small cell lung cancer cells with fenbendazole and found tumor cell death.
* The sample copy includes: Report Summary, Table of Contents,
Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2244
Since, developing a promising
molecule into an approved drug often consume considerable time and cost,
repurposing of veterinary drugs in treating diseases in humans can be effective
and have shown promising results and is expected to show cost reduction without
need to develop new drugs.
Furthermore, approval of new
fenbendazole drugs is expected to drive growth of the fenbendazole market. For
instance, in January 2018, Merck Animal Health received approval from U.S. Food
and Drug Administration (USFDA), for its Safe-Guard AquaSol, a fenbendazole
oral suspension used in the treatment and control of adult Ascaridia galli in
broiler chickens and Heterakis gallinarum in breeding chickens via drinking
water. Safe-Guard AquaSol is produced with an innovative wet-milling
technology, which produces a highly stable suspension that can be conveniently
administered to hens through drinking water.
Fenbendazole Market Restraint
Fenbendazole drug resistance due
improper or excessive usage of drugs in horses is likely to affect the growth
of fenbendazole market. For instance, according to National Equine Health
Survey (NEHS) 2016, increasing use of fenbendazole drugs in horses in the U.S.
has caused widespread resistance for the drug in these animals. According to
the same source, use of fenbendazole drugs in horses for treatment of encysted
small red worm causes gut infection in the animals.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/fenbendazole-market-2244
North America is expected to hold
dominant position in the global fenbendazole market, owing to new developments
in pet care and animal health. For instance, in June 2018, Cargill Animal
Nutrition, a U.S.-based firm launched NutreBeef Safe-Guard (fenbendazole)
Dewormer Mineral (Medicated) in one easy-to-use package. NutreBeef Safe-Guard
Dewormer Mineral combines Safe-Guard from Merck Animal Health, with a high
quality, free-choice mineral formula from Cargill Animal Nutrition. Safe-Guard
goes directly into the gastrointestinal tract of the parasite and once ingested
by the parasite, it cannot be excreted thus, accumulation of Safe-Guard in the
parasite eventually leads to parasite death.
Furthermore, Asia Pacific is
expected to witness significant growth in global fenbendazole market due to
expansions of production sites for fenbendazole by key players. For instance,
in November 2017, Lasa Supergenerics Limited, a key player in manufacturing of
Veterinary APIs in India, launched trial production of fenbendazole
intermediates along with other drugs at its manufacturing unit IV to increase
the production of fenbendazole in India.
Key players operating in the
global fenbendazole market include, Shaanxi Hanjiang Pharmaceutical Group Co.,
Ltd., Hubei KangBaoTai Fine Chemical Co., Ltd, Merck Sharp & Dohme Corp.,
Henan Purui Pharmaceutical Co., Ltd., Leo Bio-care Private Limited, Supharma
Chem., Intervet Inc., LASA Supergenerics Limited, and Jiangsu Quality Horizons
Pharmtech Co., Ltd.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2244
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment